1. Poland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Medicalgorithmics SA

Medicalgorithmics SA

GGPW:MDG
23.45
PLN
-1.35
(-5.44%)
-0.97EPS
277.18MMarket Cap
Nov 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.59
8.6
14.27
35.46
56.38
55.28
48.2
27
10.63
11
4.33
2.41
3.11
3.46
Basic EPS, GAAP
3.18
4.2
4.03
11.12
7.08
4
1.19
-3.12
-39.73
-2.08
-0.06
-1.62
-1.17
-0.97
Free Cash Flow per Basic Share
1.56
-2.33
4.24
7.48
-2.56
10.48
1.32
-0.96
-1.42
-1.06
-1.12
-2.32
-1.57
-0.02
Dividend per Share
1.1
1.35
1.6
1.77
3.21
1.42
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
23.65
26.27
28.7
49.07
46.84
52.64
54.3
47.91
9.52
9.51
9.3
7.75
6.49
6.32
Tangible Book Value per Share
22.14
23.57
25.59
-16.75
-7.76
-5.71
-3.85
1.29
-0.64
3.09
2
-0.13
-2.28
-2.77
Basic Weighted Avg Shares
3
3
3
4
4
4
4
4
5
6
10
10
10
10
Sales/Revenue/Turnover
16
30
49
128
203
199
174
112
48
63
43
24
31
34
Operating Margin (%)
63.74
46.75
43.78
36.31
20.46
12.79
0.2
-30.79
25.09
25.59
1.28
-67.88
-26.25
-13.8
Depreciation Expense
- -
1
2
5
12
12
19
16
18
4
2
4
5
5
Net Income, GAAP
11
15
14
40
26
14
4
-13
-181
-12
-1
-16
-12
-10
Effective Tax Rate (%)
19.3
19.3
19.46
6.8
8.03
12.17
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
69.27
48.89
28.23
31.35
12.56
7.23
2.46
-11.56
-373.61
-18.91
-1.34
-67
-37.71
-27.96
Working Capital
46
42
52
16
43
17
8
4
-4
46
31
13
4
2
LT Debt
- -
- -
- -
50
50
8
24
12
8
- -
- -
3
17
19
Total Equity
81
91
99
215
204
231
225
207
47
95
93
77
65
63
Return on Invested Capital (%)
10.4
13.03
17.89
23.11
14.29
7.76
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
14.05
16.92
14.68
22.04
7.89
4.64
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
14.06
16.92
14.66
29.05
14.77
8.04
2.22
-6.41
-141.82
-16.7
-0.62
-18.95
-16.48
-14.21

Capital Structure

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
2
3
LT Borrowings
16
17
19
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
395
334
277

Working Capital

PLN

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
17
17
17
Cash, Cash Equivalents & STI
3
3
3
Accounts Receivable, Net
7
9
9
Inventories
7
5
5
Total Current Liabilities
8
13
16
Payables & Accruals
- -
- -
- -
ST Debt
- -
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

PLN

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.19%
-2.5%
-16.26%
Free Cash Flow
-61.46%
43.2%
-32.28%
Net Income, GAAP
340.04%
752.9%
-27.34%
Sales/Revenue/Turnover
9.43%
-14.7%
29.09%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7
6
5
6
24
2025
7
7
7
10
31
2026
10
- -
- -
- -
- -

Quarterly Earnings Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.4
-0.53
-0.21
-0.47
-1.62
2025
-0.42
-0.25
-0.41
-0.09
-1.17
2026
-0.22
- -
- -
- -
- -

Quarterly Dividends Per Share

PLN

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Krzysztof Siemionow
Full Time Employees
109
Sector
Health technology
Industry
Medical specialties
Address
Central Tower Warsaw MZ Poland 02-001
IPO Date
Nov 9, 2011
Website
medicalgorithmics.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Medicalgorithmics S.A. delivers advanced cardiac diagnostic and monitoring solutions across global markets, including Poland, the United States, and numerous other countries. The company’s flagship offering, PocketECG, is a comprehensive system designed for arrhythmia detection, providing full-disclosure ECG data, in-depth analysis, and detailed diagnostic reporting, functioning seamlessly as a long-term Holter, event monitor, and mobile cardiac telemetry device. Medicalgorithmics also pioneers AI-driven technologies like DeepRhythmAI (DRAI), an FDA-approved algorithm for rapid and precise heart rhythm analysis, and the cloud-based DeepRhythm Platform (DRP), which integrates with diverse hardware for enhanced ECG interpretation. Complementing these, Kardiobeat.ai offers extended Holter monitoring with AI diagnostics, while VCAST provides an innovative AI-based virtual cardiac stress test for non-invasive coronary artery disease assessment. Since its establishment in 2005, and headquartered in Warsaw, Poland, the firm has strategically pivoted to emphasize high-margin software licensing and AI algorithm integration with third-party systems, expanding its service revenue and global client base, including significant growth in the US market and new entries into regions like the Middle East.